Company Data
Kazia Therapeutics Limited
Ticker
KZIA
Current Price
$8.07 4.4%
Market Cap
$11.0M
Price Target
Refer to Report
Volume
4.7K
52wk Range
$2.86 - $195.25
Overview
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing GDC-0084, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others.